![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1621999
¼¼°èÀÇ ÀÚµ¿ ºÐ¼®±â ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ¹üÀ§ ¹× ¿¹ÃøGlobal Automated Analyzers Market Size By Product (Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers), By Application (Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics), By Geographic Scope and Forecast |
ÀÚµ¿ ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 75¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2031³â¿¡´Â 151¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2031³âÀÇ ¿¹Ãø ±â°£ Áß CAGR 7.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÃÖ±Ù ÀÚµ¿È ¹× ÅëÇÕÈ Ãß¼¼·Î ÀÎÇØ Çõ½ÅÀûÀÎ Á¦Ç°ÀÌ ½ÃÀå¿¡ Ãâ½ÃµÇ¾î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº Á¦¾àȸ»ç¿Í »ý¸í°øÇРȸ»çµéÀÌ ½Å¾à°³¹ßÀ» À§ÇØ ¸é¿ªÃøÁ¤ ½Ã½ºÅÛÀ» ÀÚÁÖ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ¾÷°è ±â¾÷Àº ¸é¿ªÃøÁ¤ ½Ã½ºÅÛÀÇ ±â´É, 󸮷®, ¸Þ´º È®Àå µîÀÇ ¾ÆÀ̵ð¾î·Î °æÀïÇÏ¿© º´¿ø°ú ½ÇÇè½Ç¿¡ Á¢±ÙÇÏ¿© ºñÁî´Ï½º Á¡À¯À²À» È®º¸Çϱâ À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ÀÚµ¿ ºÐ¼®±â ½ÃÀå º¸°í¼´Â ½ÃÀåÀÇ Àü¹ÝÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ºÎ¹®, µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ ½ÃÀå¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ»ÇÏ´Â ¿äÀÎ µîÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®ÇÕ´Ï´Ù.
¼¼°èÀÇ ÀÚµ¿ ºÐ¼®±â ½ÃÀå Á¤ÀÇ
ÀÚµ¿ ºÐ¼®±â´Â äÃëÇÑ ¸¹Àº »ý¹°ÇÐÀû »ùÇÃÀÇ ´Ù¾çÇÑ ÈÇÐ ¼ººÐ ¹× ±âŸ ¸Å°³ º¯¼ö¸¦ ÃÖ¼ÒÇÑÀÇ Àη Áö¿øÀ¸·Î ½Å¼ÓÇϰí È¿À²ÀûÀ¸·Î ÃøÁ¤Çϵµ·Ï ¼³°èµÈ ÀÇ·á °Ë»ç ÀåºñÀÔ´Ï´Ù. À§ÀÇ ¹ßÀü°ú ÀÚµ¿ ºÐ¼®±âÀÇ ÀåÁ¡Àº ÀÚµ¿ µ¥ÀÌÅÍ ¼öÁý, ½Ç½Ã°£ ÀÚµ¿È¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ´ë±Ô¸ð °øÁ¤ Á¦¾î, È¿À²ÀûÀÎ ¸Å°³º¯¼ö ¸ð´ÏÅ͸µ ¹× ÀÚµ¿ º¯¼ö Á¶Á¤ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¶ÇÇÑ ±¤¹üÀ§ÇÑ »ùÇà ºÐ¼®À» Á¦°øÇϰí Áï°¢ÀûÀÎ °á°ú »ý¼ºÀ» ¿ëÀÌÇϰÔÇϸç ÇâÈÄ ÀÇ·á ½Ã¼³, ¿Ü·¡ Áø·á¼Ò, ÀÀ±Þ½Ç ¹× ¿Ü°ú º´µ¿¿¡¼ÀÇ Àû¿ë °¡´É¼ºÀ» ¹Ý¿µÇÕ´Ï´Ù.
¼¼°èÀÇ ÀÚµ¿ ºÐ¼®±â ½ÃÀå °³¿ä
°¨¿°º´ Áõ°¡·Î ÀÎÇØ ÀÇ·á ¼ºñ½º ÀÚ¿ø¿¡ ¾öû³ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. °¨¿°¼º Áúȯ Áõ°¡´Â ´Ù¾çÇÑ °Ç° ¹®Á¦¸¦ Áö¼ÓÀûÀ¸·Î ¾ß±âÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ESR(È£»ê±¸ ħ°¼Óµµ) °Ë»ç Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ» °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â Á¤ºÎ ¹× »ê¾÷°èÀÇ ±ÔÁ¦ Áؼö Àǹ«È, ÅëÇÕ ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ·¹°Å½Ã ½Ã½ºÅÛ¿¡¼ »ó¿ë ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀº µ¥ÀÌÅÍ, ¸®¼Ò½º ¹× ¿öÅ©Ç÷ο츦 °ü¸®ÇÒ ¼ö ÀÖ´Â À¯¿¬ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÏ´Â ¼Ö·ç¼ÇÀ¸·Î ´ëºÎºÐÀÇ ½ÇÇè½Ç¿¡¼ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¼¼°è ÀÚµ¿ ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» ±àÁ¤ÀûÀ¸·Î ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àüü ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â Á¦¾à°ú À庮µµ ÀÖ½À´Ï´Ù. Àα¸°¡ ÀûÀº Áö¿ª°ú ½ÅÈï ±¹°¡ ½ÃÀå¿¡¼´Â ÇÊ¿äÇÑ ÀÇ·á ÀηÂÀ» È®º¸ÇÏÁö ¸øÇÏ´Â µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ±¹°¡ÀÇ °æ¿ì, °£¼ÒÈµÈ ¹ý·üÀÌ Á¸ÀçÇÏÁö ¾Ê´Â °Íµµ ¿¹Ãø ±â°£ Áß ¼ºÀåÀ» µÐȽÃų °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ ³ôÀº ºÐ¼® Àåºñ ºñ¿ë°ú ºñÈ¿À²ÀûÀÎ °Ë»ç ÇÁ·Î¼¼½º, ¼÷·ÃµÈ ÀηÂÀÇ ºÎÁ·Àº Àüü ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ÀáÀçÀû ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ±â¼ú ¹ßÀü°ú ½ÅÈï ½ÃÀåÀÇ ¹Ì°³Ã´ ÀáÀç·ÂÀº À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
Automated Analyzers Market size was valued at USD 7.51 Billion in 2024 and is projected to reach USD 15.19 Billion by 2031, growing at a CAGR of 7.3% during the forecasted period 2024 to 2031. Recent trends of automation and integration have led to the introduction of innovative products within the market, thus driving the market. Numerous pharmaceutical and biotechnology companies are frequently using them for drug discovery targets. Industry players are competing on the idea of immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories. The Global Automated Analyzers Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Automated Analyzers Market Definition
An automated analyzer may be a medical laboratory instrument that's designed to live different chemical compositions and other parameters in many collected biological samples in a fast and efficient manner, with minimal human assistance. The benefits of the above-mentioned advancements and automated analyzers are automatic data acquisition, greater process control allowing real-time automation, efficient parameter monitoring, and automatic variable adjustment. These tools also offer an analysis of a good range of samples and facilitate the immediate generation of results, reflecting their potential applications within the medical care unit, outpatient clinics, and emergency as well as surgical wards in the future.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Automated Analyzers Market Overview
The growing prevalence of infectious diseases imposes an immense difficulty on healthcare service resources. A growing number of infectious diseases are continuously driving to various health hazards, which are likely to contribute to the rising number of ESR (eosinophils sedimentation rate) tests. Moreover, major factors that are contributing towards the growth of the market include the compulsion from the respective governments and industries to comply with the regulations, and the growing demand for integrated healthcare systems. The shift from legacy systems to commercial solutions was favored by mostly all the laboratories, as these solutions provide flexible and reliable methods to manage data, resources, and workflows. These have positively anticipated propelling the growth of the global Automated Analyzers Market.
There are certain restrictions and barriers faced that will hinder the overall market growth. The factors such as the unavailability of required healthcare personnel in underdeveloped or developing regions are limiting the market growth. Also, the absence of streamlined laws in emerging economies is estimated to sluggish growth during the forecast period. Further, the high cost of analyzers and inefficient testing processes, coupled with a lack of a skilled workforce is the potential restraints hampering the overall growth of the global market. Nevertheless, the improvements in technologies and untapped potential in emerging markets offer lucrative growth opportunities.
The Global Automated Analyzers Market is Segmented on the basis of Product, Application, and Geography.
Based on Product, the market is bifurcated into Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Others. The immune-based analyzers segment holds the largest market share during the forecast period. The factors that can be attributed to increasing use due to its high sensitivity and accuracy of analyte detection resulting in accurate diagnosis are accelerating the demand for the immune-based analyzer.
Based on Application, the market is bifurcated into Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Others. The drug discovery segment holds the largest market share during the forecast period. The rising number of diagnostic laboratories and an increasing number of corporate hospital chains will foster market demand.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.